ArticleRSC advances2026
Defect-engineered lignite-derived carbon/NiCo
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of robust materials for nonenzymatic glucose sensing remains challenging due to material cost, instability, and limited mechanistic understanding. Moreover, many existing reports lack validation using real samples, making their real-world applicability uncertain. We report a novel defect-engineered interface composed of spinel nickel cobalt oxide and lignite-derived porous carbon (NCO/LC). The engineered carbon-oxide interface induces oxygen-vacancy-rich active sites, promoting rapid redox kinetics and electrocatalytic glucose oxidation. Initial electrochemical characterization was performed using a glassy carbon electrode (GCE) to establish the sensing mechanism, followed by successful translation to a screen-printed electrode (SPE) for practical validation and real sample analysis. The NCO/LC-modified GCE exhibited a high sensitivity of 2564.63 µA cm
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.